1195 Discovery of CBO421, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1797630927653830656 |
|---|---|
| author | María Hernández Simon Dohrmann James Levin Nicholas Dedeic Amanda Almaguer Doug Zuill Elizabeth Abelovski Rajvir Grewal Joanne Fortier Qiping Zhao Karin Amundson Madison Moniz Hongyuan Chen Dhanya Panicker Thanh Lam Thomas P Brady Allen Borchardt Jason N Cole Leslie W Tari |
| author_facet | María Hernández Simon Dohrmann James Levin Nicholas Dedeic Amanda Almaguer Doug Zuill Elizabeth Abelovski Rajvir Grewal Joanne Fortier Qiping Zhao Karin Amundson Madison Moniz Hongyuan Chen Dhanya Panicker Thanh Lam Thomas P Brady Allen Borchardt Jason N Cole Leslie W Tari |
| author_sort | María Hernández |
| collection | DOAJ |
| first_indexed | 2024-03-11T11:14:44Z |
| format | Article |
| id | doaj.art-b93c42d0c77e42c1ac770d82acb13595 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-03-11T11:14:44Z |
| publishDate | 2023-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-b93c42d0c77e42c1ac770d82acb135952023-11-11T07:20:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262023-11-0111Suppl 110.1136/jitc-2023-SITC2023.11951195 Discovery of CBO421, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancerMaría Hernández0Simon Dohrmann1James Levin2Nicholas Dedeic3Amanda Almaguer4Doug Zuill5Elizabeth Abelovski6Rajvir Grewal7Joanne Fortier8Qiping Zhao9Karin Amundson10Madison Moniz11Hongyuan Chen12Dhanya Panicker13Thanh Lam14Thomas P Brady15Allen Borchardt16Jason N Cole17Leslie W Tari1813 Department of Pediatrics, Hospital Materno Infantil de Las Palmas, Las Palmas, SpainCidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USACidara Therapeutics, San Diego, CA, USA |
| spellingShingle | María Hernández Simon Dohrmann James Levin Nicholas Dedeic Amanda Almaguer Doug Zuill Elizabeth Abelovski Rajvir Grewal Joanne Fortier Qiping Zhao Karin Amundson Madison Moniz Hongyuan Chen Dhanya Panicker Thanh Lam Thomas P Brady Allen Borchardt Jason N Cole Leslie W Tari 1195 Discovery of CBO421, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer Journal for ImmunoTherapy of Cancer |
| title | 1195 Discovery of CBO421, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer |
| title_full | 1195 Discovery of CBO421, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer |
| title_fullStr | 1195 Discovery of CBO421, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer |
| title_full_unstemmed | 1195 Discovery of CBO421, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer |
| title_short | 1195 Discovery of CBO421, a first-in-class drug Fc-conjugate (DFC), targeting CD73 in cancer |
| title_sort | 1195 discovery of cbo421 a first in class drug fc conjugate dfc targeting cd73 in cancer |
| work_keys_str_mv | AT mariahernandez 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT simondohrmann 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT jameslevin 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT nicholasdedeic 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT amandaalmaguer 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT dougzuill 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT elizabethabelovski 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT rajvirgrewal 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT joannefortier 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT qipingzhao 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT karinamundson 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT madisonmoniz 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT hongyuanchen 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT dhanyapanicker 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT thanhlam 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT thomaspbrady 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT allenborchardt 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT jasonncole 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer AT lesliewtari 1195discoveryofcbo421afirstinclassdrugfcconjugatedfctargetingcd73incancer |